Skip to main content

UiPath, Inc. (PATH) Stock Analysis

Recovery setup · Catalyst-Driven edge

SellVALUE-TRAP 1/5Moderate Confidence

Technology · Software - Infrastructure

Sell if holding. At $10.64, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 3.9): -1.5; Concentration risk — Product: UiPath Platform.

UiPath provides an enterprise agentic automation platform (UiPath Platform™) combining RPA, AI agents, process orchestration, and governance capabilities, primarily selling to large enterprises globally via direct and channel sales. Revenue is subscription-based; a limited... Read more

$10.64+16.8% A.UpsideScore 6.4/10#5 of 80 Software - Infrastructure
Stop $9.89Target $12.42(analyst − 10%)A.R:R 1.3:1
Analyst target$13.80+29.7%16 analysts
$12.42our TP
$10.64price
$13.80mean
$17

Sell if holding. At $10.64, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 3.9): -1.5; Concentration risk — Product: UiPath Platform. Chart setup: Death cross but MACD improving, RSI 58. Score 6.4/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 27d clear, semi cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

Thesis

Rewards
Strong earnings beat streak (3/4)
High-quality business
Attractive valuation
Risks
Concentration risk — Product: UiPath Platform
Leverage penalty (D/E 3.9): -1.5
Elevated risk factors

Key Metrics

P/E (TTM)19.8
P/E (Fwd)11.5
Mkt Cap$5.4B
EV/EBITDA53.0
Profit Mgn17.5%
ROE14.4%
Rev Growth13.6%
Beta1.02
DividendNone
Rating analysts28

Quality Signals

Piotroski F8/9

Options Flow

P/C0.60bullish
IV80%elevated
Max Pain$5-53.0% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHProductUiPath Platform
    10-K Item 1A: 'Because we derive substantially all of our revenue from our UiPath Platform™, failure of this platform to satisfy customer demands could adversely affect our business'

Material Events(8-K, last 90d)

  • 2026-03-25Item 5.02LOW
    UiPath appointed Raghavendra Malpani as Chief Product and Technology Officer effective March 25, 2026, promoted from his role as CTO. No change in reporting structure noted.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer

Rating Breakdown

1 floor-breaker

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
0.7
Bollinger
3.7
Support Resistance
3.7
Gap
4.0
GatesA.R:R 1.3 < 1.5@spotMomentum 5.5<5.5 (soft — BUY_NOW allowed but watch)Death cross (50MA < 200MA)Momentum 5.5>=4.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 27d clearSEMI CYCLE PEAK CLEARRecoverySuitability: Moderate
RSI
58 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $9.28Resistance $11.42

Price Targets

$10
$12
A.Upside+16.7%
A.R:R1.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeCautious

Risk Alerts

! Reward/Risk 1.3:1 at current price — below 1.5:1 minimum

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-05-28 (27d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is PATH stock a buy right now?

Sell if holding. At $10.64, A.R:R 1.3:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 3.9): -1.5; Concentration risk — Product: UiPath Platform. Chart setup: Death cross but MACD improving, RSI 58. Prior stop was $9.89. Score 6.4/10, moderate confidence.

What is the PATH stock price target?

Take-profit target: $12.42 (+16.8% upside). Prior stop was $9.89. Stop-loss: $9.89.

What are the risks of investing in PATH?

Concentration risk — Product: UiPath Platform; Leverage penalty (D/E 3.9): -1.5; Elevated risk factors.

Is PATH overvalued or undervalued?

UiPath, Inc. trades at a P/E of 19.8 (forward 11.5). TrendMatrix value score: 8.2/10. Verdict: Sell.

What do analysts say about PATH?

28 analysts cover PATH with a consensus score of 3.4/5. Average price target: $14.

What does UiPath, Inc. do?UiPath provides an enterprise agentic automation platform (UiPath Platform™) combining RPA, AI agents, process...

UiPath provides an enterprise agentic automation platform (UiPath Platform™) combining RPA, AI agents, process orchestration, and governance capabilities, primarily selling to large enterprises globally via direct and channel sales. Revenue is subscription-based; a limited number of customers represent a substantial portion of revenue and ARR.

Related stocks: PICS (PicS N.V.) · DLO (DLocal Limited) · KSPI (Joint Stock Company Kaspi.kz - ) · STNE (StoneCo Ltd.) · GEN (Gen Digital Inc.)